Tiaa, Fsb Care Dx, Inc. Transaction History

Tiaa, Fsb

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$20.49 - $39.72 $1.23 Million - $2.39 Million	-60,204 Closed	0 $0
Q2 2021 Jul 21, 2021	SELL	$63.02 - $95.11 $397,719 - $600,239	-6,311 Reduced 9.49%	60,204 $5.51 Million
Q1 2021 Apr 21, 2021	SELL	$57.62 - $95.6 $679,051 - $1.13 Million	-11,785 Reduced 15.05%	66,515 $4.53 Million
Q4 2020 Jan 21, 2021	BUY	$41.43 - $77.09 $15,329 - $28,523	370 Added 0.47%	78,300 $5.67 Million
Q3 2020 Oct 13, 2020	BUY	$30.88 - $37.94 $13,556 - $16,655	439 Added 0.57%	77,930 $2.96 Million
Q2 2020 Jul 15, 2020	BUY	$18.95 - $35.43 $60,071 - $112,313	3,170 Added 4.27%	77,491 $2.75 Million
Q1 2020 Apr 21, 2020	BUY	$13.94 - $28.25 $212,598 - $430,840	15,251 Added 25.82%	74,321 $1.62 Million
Q4 2019 Jan 13, 2020	SELL	$19.24 - $28.41 $190,976 - $281,997	-9,926 Reduced 14.39%	59,070 $1.27 Million
Q3 2019 Oct 08, 2019	BUY	$20.03 - $40.08 $6,249 - $12,504	312 Added 0.45%	68,996 $1.56 Million
Q2 2019 Aug 14, 2019	BUY	$25.78 - $39.77 $1.77 Million - $2.73 Million	68,684 New	68,684 $2.47 Million
Q1 2019 Apr 15, 2019	SELL	$22.09 - $39.21 $220,900 - $392,100	-10,000 Closed	0 $0
Q4 2018 Apr 15, 2019	BUY	$19.89 - $30.02 $198,900 - $300,200	10,000 New	10,000 $251,000

Ticker CDNA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 53,458,100
Market Cap $1.18B
Description
CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...

Get notified when there are updates to the investment portfolio of Tiaa, Fsb, based on Form 13F filings with the SEC.

Stay updated on Tiaa, Fsb with notifications on news.